✦ LIBER ✦

Prolonged bone marrow aplasia of refractory porolymphocytoid variant of B-cell chronic lymphocytic leukemia related to fludarabine treatment

✍ Scribed by P. L. Zinzani; M. Tabanelli; M. Bendandi; S. Tura

Book ID: 114791789
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 190 KB
Volume: 53
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1994.tb00182.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of single-agent bortezomi

Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia

✍ Stefan Faderl; Kanti Rai; John Gribben; John C. Byrd; Ian W. Flinn; Susan O'Brie 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

A phase II study of cladribine treatment

A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211

✍ Byrd, J C; Peterson, B; Piro, L; Saven, A; Vardiman, J W; Larson, R A; Schiffer, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB

Fatal adenovirus infection during alemtu

Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-CELL chronic lymphocytic leukemia

✍ Nina Cavalli-Björkman; Eva Ösby; Jeanette Lundin; Mats Kalin; Anders Österborg; 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 61 KB

Bone marrow infiltration pattern in B-ce

Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd ζ-associated protein (ZAP-70)

✍ Ulrika Schade; Oliver Bock; Sylke Vornhusen; Anna Jäger; Guntram Büsche; Ulrich 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 425 KB

Early Results of a Phase II Study Adding

Early Results of a Phase II Study Adding Peri-Transplant Rituximab to Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients (PTS) with High-Risk Fludarabine-Refractory Chronic Lymphocytic Leukemia (Cll)

✍ M.L. Sorror; B. Storer; B.M. Sandmaier; T. Chauncey; B. Bruno; N.N.S. Andersen; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Treatment of patients (pts) with chemoth

Treatment of patients (pts) with chemotherapy-refractory chronic lymphocytic leukemia (CLL) with nonmyeloablative (NM) conditioning and hematopoietic cell transplantation (HCT) from HLA-matched related (MRD) or unrelated donors (URD)

✍ M.L. Sorror; M.B. Maris; B.M. Sandmaier; M. Jain-Stuart; B. Storer; U. Hegenbart 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB